Trial reportBMC primary care2026
Hemoglobinometry at the point of care with activation of a hospital transfusion pathway versus usual care for the early detection of anaemia in primary care: the ANHEMOG randomized controlled trial.
Trial report in BMC primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04757909 (Early Detection of Anemizations in Primary Care Using Hemoglobinometer), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Early Detection of Anemizations in Primary Care Using Hemoglobinometer: Randomized Clinical Trial Protocol.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAnaemia is a common condition associated with increased morbidity, mortality, and health resource utilization. Early detection and timely treatment are essential to improve prognosis and quality of life. The aim of this study was to evaluate the effect of point-of-care haemoglobinometry combined with activation of a hospital transfusion circuit compared with usual care in patients with transfusion-dependent chronic anaemia managed in primary care settings in Catalonia, Spain.
methodsA randomized controlled clinical trial was conducted between 2018 and 2021 in primary care centres of the Catalan Institute of Health. Patients were randomly assigned to an intervention group (monthly capillary haemoglobin monitoring using a haemoglobinometer and activation of a transfusion circuit) or a control group (standard venous blood monitoring according to usual practice). Descriptive statistics were calculated, and between-group comparisons were performed using appropriate statistical tests.
resultsPatients in the intervention group had shorter hospital stay (median = 2 vs. 12.5 days; p = 0.319), although these differences were not statistically significant. Median values of emergency room visits were significantly lower in the intervention group (1) compared to the control group (4), p < 0.001, as was total emergency room time in hours (4 vs. 70; p < 0.001). At 12 months, quality of life scores were significantly higher in the intervention group (15 vs. -2; p < 0.001).
conclusionsPoint-of-care haemoglobinometry combined with an organized transfusion circuit improves quality of life and reduces emergency service utilization in patients with transfusion-dependent anaemia, with important implications for clinical practice and healthcare resource optimization.
trial registrationClinicalTrials.gov NCT04757909. Submitted February 16, 2021.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.